Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 350 participants.

Also called NCT01578122

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 350 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01578122
Other papers using this trial's data
  • 25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial The Lancet. Haematology, 2022-12 DOI, PubMed 36455606

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01578122. Randomized; double masking; primary purpose treatment. Start 2012-06-29 (actual); primary completion 2019-06-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
Acronym
CELEST
Condition
Post-thrombotic Syndrome
Intervention (Device)
25mmHg ECS
Intervention (Device)
35 mmHg ECS
Lead sponsor
Laboratoires Innothera (class: industry)
Collaborator
University Hospital, Grenoble (class: other)
Collaborator
Floralis (class: industry)

Record details

Record id
cardio:ct-nct01578122
Content hash
1fe4214d0a3e325f0cbb7756aa66916c7fb91a91c5171fc3658d3218f039be64